Wayne A Gordon, PhD Email Wayne Gordon
- PROFESSOR | Rehabilitation Medicine
- ASSOCIATE PROFESSOR | Psychiatry
- Hospital Affiliation
- The Mount Sinai Hospital
- Department of Rehabilitation Medicine 212-824-8372212-824-8372
Dr. Gordon is the Jack Nash Professor and Vice Chair of the Department of Rehabilitation Medicine at the Icahn School of Medicine at Mount Sinai. He is also Chief of the Rehabilitation Psychology and Neuropsychology service. Dr. Gordon is a Diplomate in Clinical Neuropsychology and a Fellow in the Academy of Behavioral Medicine Research.
He has published more than 100 articles and book chapters. He is the project director of the Mount Sinai Brain Injury Research Center (BIRC) and the .
Dr. Gordon has received several awards during his career including a recognition award in 1996 from the NYS Department of Health for "his visionary work" in TBI. He provides diagnostic (neuropsychological evaluation) and treatment (psychotherapy, cognitive remediation) for individuals who have sustained a brain injury from trauma, a medical event or exposure to toxic substances, such as mold.
In the News
Rehabilitation specialist Dr. Gordon discusses traumatic brain injuries in The Daily News feature The Daily Check Up. View the PDF.
- Brain Aneurysm
- Brain Tumor And Brain Cancer
- Chronic Fatigue Syndrome
- Intracranial Hemorrhage
- Mild Cognitive Impairment
- Multiple Sclerosis
- Parkinson's Disease
- Spinal Cord Injury
- Transient Ischemic Attack
- Traumatic Brain Injury
PHD, Yeshiva University
Traumatic Brain Injury Research
Develop better rehabilitation interventions aimed at improved outcomes for individuals with TBI.
Develop approaches to better identify those individuals with mild TBI who are at risk of long-term disability.
Develop a method to identify the long-term needs of individuals with TBI, as the basis for documenting disablement and for prioritizing the elements of a secondary injury control agenda aimed at secondary prevention.
Ashman TA, Cantor JB, Gordon WA, Sacks A, Spielman L, Egan M, Hibbard MR. Comparison of Cognitive Functioning in Older Adults with and without Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 2008; 23(3): 139-148.
Cantor JB, Ashman TA, Gordon WA, Ginsberg A, Engmann C, Egan M, Spielman L, Dijkers M, Flanagan S. Fatigue after Traumatic Brain Injury and its Impact on Participation and Quality of Life. Journal of Head Trauma Rehabilitation 2008; 23(14): 41-51.
Ashman TA, Cantor JB, Gordon WA, Spielman L, Egan M, Ginsberg A, Engmann C, Dijkers M, Flanagan S. Objective Measurement of Fatigue Following Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 2008; 23(1): 33-40.
Breed S, Sacks A, Ashman TA, Gordon WA, Dahlman K, Spielman L. Cognitive Functioning among Individuals with Traumatic Brain Injury, Alzheimer's Disease, and No Cognitive Impairments. Journal of Head Trauma Rehabilitation 2008; 23(3): 149-157.
Gordon WA, Zafonte R, Cicerone K, Cantor J, Brown M, Lombard L, Goldsmith R, Chanda T. TBI State of the Science Review. American Journal of Physical Medicine and Rehabilitation 2006; 85(4): 343-382.
Gordon WA, Cantor J, Ashman T, Brown M. Treatment of Post-TBI Executive Dysfunction: Application of Theory to Clinical Practice. Journal of Head Trauma Rehabilitation 2006; 21(2): 156-167.
Cantor JB, Gordon WA, Ashman TA. Screening for Brain Injury in Schoolchildren [abstract]. Journal of Head Trauma Rehabilitation 2006; 21: 424-424.
Cantor J, Ashman T, Schwartz M, Gordon WA, Hibbard MR, Brown M, Spielman L, Charatz HJ, Cheng Z. The Role of Self-Discrepancy Theory in Understanding Post-TBI Affective Disorders: A pilot study. Journal of Head Trauma Rehabilitation 2005; 20(6): 527-543.
Brown M, Dijkers M, Gordon WA, Ashman T, Charatz H, Cheng Z. Participation Objective, Participation Subjective: A Measure of Participation Combining Outsider and Insider Perspectives. Journal of Head Trauma Rehabilitation 2004; 19: 459-81.
Gordon WA, Canto JB. The Diagnosis of Cognitive Impairment Associated with Exposure to Mold. Advances in Applied Microbiology 2004; 55: 361-374.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Gordon did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.